Factor VIII products and inhibitors in severe hemophilia A

New England Journal of Medicine

Volumn 368, Issue 15, 2013, Pages 1456-1457

  Iorio, Alfonso ^a   Skinner, Mark W ^b   Makris, Mike ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b not available   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 8;

CELL STRAIN BHK; CHO CELL; CLINICAL DECISION MAKING; HEMOPHILIA A; HUMAN; LETTER; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

EID: 84875912773     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1301995     Document Type: Letter

References (2)

1. Gouw SC, van der Bom JG, Ljung R, et al. Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med 2013;368:231-9.
2. Iorio A, Puccetti P, Makris M. Clotting factor concentrate switching and inhibitor development in hemophilia A. Blood 2012;120:720-7.